Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Buy
7,214
+2,469
+52% +$438K ﹤0.01% 1311
2026
Q1
$719K Sell
4,745
-3,993
-46% -$605K ﹤0.01% 1404
2025
Q4
$929K Buy
8,738
+4,513
+107% +$507K ﹤0.01% 1288
2025
Q3
$493K Sell
4,225
-566
-12% -$50.7K ﹤0.01% 1332
2025
Q2
$419K Hold
4,791
﹤0.01% 1419
2025
Q1
$253K Hold
4,791
﹤0.01% 1632
2024
Q4
$435K Buy
4,791
+845
+21% +$66.4K ﹤0.01% 1589
2024
Q3
$321K Buy
3,946
+1,054
+36% +$103K ﹤0.01% 1533
2024
Q2
$376K Buy
2,892
+1,711
+145% +$163K ﹤0.01% 1410
2024
Q1
$93.5K Buy
+1,181
New +$92.8K ﹤0.01% 1775
2022
Q3
Sell
-3,198
Closed -$82K 1847
2022
Q2
$82K Sell
3,198
-3,189
-50% -$91.2K ﹤0.01% 1483
2022
Q1
$204K Buy
+6,387
New +$225K ﹤0.01% 1387

Other funds holding CAMT

Amundi's CAMT Position: Q2 2026 in Review

Amundi increased its Camtek (CAMT) stake by 52% in Q2 2026, buying an estimated $438K and bringing the position to 7,214 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1311.

Amundi first reported a position in CAMT in Q1 2022 and has held it in 12 quarters since. 235 funds tracked by Wall St. Rank hold CAMT as of Q2 2026.

  • Amundi held 7,214 shares of Camtek worth $1.18M as of Q2 2026.
  • Amundi bought 2,469 Camtek shares in Q2 2026, an estimated $438K.
  • Camtek made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1311 holding.
  • Amundi first reported a position in Camtek in Q1 2022 and has held it in 12 quarters since.
  • 235 funds tracked by Wall St. Rank held Camtek as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.